NCT07533903招募中不适用
Functional Outcomes and Control Using Synchron BCI - Australia (FOCUS-AUS)
Synchron, Inc.1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2026年5月22日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Device-related serious adverse events resulting in death or permanently increased disability up to 90 days after implant.
研究概览
简要总结
Functional Outcomes and Control Using Synchron BCI - Australia (FOCUS-AUS)
详细描述
The Synchron BCI motor neuroprosthesis is an implanted brain-computer interface indicated for adults with bilateral upper-limb motor impairment. The Synchron BCI is intended to replace the function of motor neurons by detecting, translating and transmitting motor-related brain signals to restore clinically meaningful control of digital devices.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Able to provide informed consent to participate in the study.
- •Bilateral upper-limb paresis or Amyotrophic lateral sclerosis (ALS) with bilateral upper limb paresis
- •The underlying condition causing motor impairment must be refractory to treatment and have been present for a minimum of twelve months.
- •Aged 21 years or older
- •Life expectancy greater than 12 months post-implantation
- •Preserved precentral gyrus assessed using CT
- •Suitable vascular anatomy assessed using CT venography
- •Suitable anatomy for subcutaneous pocket creation
- •Able to undergo anesthesia
- •Willing and able to comply with investigational requirements, including clinical testing visits and training visits in the home.
- •Caregiver(s) willing and able to facilitate study visits, including visits at the study site and in the home, and BCI use outside of study visits (e.g. device charging)
- •Patient and caregiver fluent in English
- •Suitable home environment for BCI training, including an internet connection
排除标准
- •Unrealistic expectations regarding the potential benefits of the device.
- •Active infection or unexplained fever in the 48 hours prior to informed consent
- •Major psychiatric disorder that may adversely impact the participant's safety or study compliance, including severe depression, psychotic features, personality disorder, severe emotional lability, or substance abuse.
- •Dementia or cognitive dysfunction that would impact the participant's ability to participate in study activities.
- •Active implanted device (e.g., deep brain stimulator, cardiac defibrillator, pacemaker, vagal nerve stimulator, spinal cord stimulator, diaphragmatic pacer, etc.).
- •Known allergy to patient-contacting materials included in the implanted device
- •Contraindication to angiographic imaging or iodine contrast media.
- •History of central venous sinus thrombosis.
- •Recent history of new venous thromboembolic event (in the 6 months prior to implant) or recurrent history of venous thromboembolic disease
- •Contraindication to antithrombotic therapy.
- •Participant is at substantially increased risk of infection, including immunocompromised status, recurrent infection, or poorly controlled diabetes mellitus.
- •Significant risk of non-healing of the subcutaneous pocket incision, including history of chronic non-healing surgical wounds or poorly controlled diabetes mellitus.
- •Pregnant or breast feeding.
- •Patients who are currently enrolled in any other clinical trial that would confound interpretation of safety or effectiveness data or may interfere with the ability to meet study requirements.
- •Any other disease or disorder that could significantly affect participation in the study. Examples may include corrected vision insufficient for viewing computer screens or hearing insufficient for following verbal instructions, which might impact the participant's ability to participate in BCI training and testing.
研究组 & 干预措施
Prospective, single-arm, open label study
Experimental
Single Arm
干预措施: Stentrode (Device)
结局指标
主要结局
Device-related serious adverse events resulting in death or permanently increased disability up to 90 days after implant.
时间窗: 3 Months
次要结局
- Device-related serious adverse events resulting in death or permanently increased disability up to 1 year after implant.(12 Months)
- Target vessel patency assessed using CT venography at 90 days and 365 days after implant(3 Months and 12 Months)
- Device migration assessed using CT imaging at 90 days and 365 days after implant(3 Months and 12 Months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Functional Outcomes and Control Using Synchron BCI - CanadaMotor Neuron DiseaseNCT07446114Synchron, Inc.10
尚未招募
2 期
Cognitive exercise therapy for Improving upper limb functions in patients with Acquired Brain Injury.CTRI/2024/09/073648Christian Medical College40
招募中
不适用
Psychosocial Factors and Efficacy of Remote Cognitive Remediation for Post-Traumatic Stress DisorderNCT07309302Université du Québec a Montréal64
Unknown
不适用
面向卒中后上肢功能康复的 MI-BCI 联合神经调控技术的应用研究ChiCTR2500115787徐州市科技局卫生健康面上项目
招募中
Unknown
脑机接口联合功能性电刺激对右侧大脑损伤患者上肢功能及大脑激活的研究脑卒中ChiCTR250010287634